The Safety, Feasibility and Efficacy of NouvNeu001 for Parkinson's Disease
Clinical trial NCT07028632 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07028632
- Sponsor
- iRegene Therapeutics Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2026-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.